Aptar Reports 98% Renewable Electricity in 2025 Sustainability Update

AptarGroup has released its 2025 Corporate Sustainability Report, outlining progress across its global sustainability strategy and reporting that 98% of its electricity was sourced from renewable sources by the end of 2025.

The report, titled Progress in Motion, covers Aptar’s global operations from January 1 to December 31, 2025. The company frames its sustainability strategy around three pillars: Care, Collaboration and Circularity. These areas cover operational impacts, employee and community considerations, customer and supplier engagement, and efforts to support more circular product systems.

Aptar is a major supplier of drug delivery, dosing, dispensing and protection technologies, serving markets including pharmaceuticals, beauty, personal care, food, beverage and home care. Its products include dispensing pumps, closures, aerosol valves, elastomeric primary packaging components, active material science solutions and digital health technologies.

Because many of these products are linked to plastic packaging, healthcare delivery and consumer goods supply chains, the company’s sustainability performance is relevant not only to its own operations but also to the Scope 3 and product design priorities of its customers.

Renewable Electricity Reaches 98%

The most prominent operational metric in the 2025 report is renewable electricity. Aptar said 98% of its electricity was sourced from renewable sources at year-end 2025.

The company linked this progress to power purchase agreements in Europe and North America, which it said support more localized renewable energy supply dedicated to Aptar and contribute to progress toward its science-based targets.

For manufacturers of packaging and dispensing systems, electricity procurement is a key lever for reducing Scope 2 emissions. Renewable power can reduce reported operational emissions, but its credibility depends on procurement quality, geography, contract structure and assurance.

Aptar’s reference to regional power purchase agreements is therefore important, as it suggests a move beyond generic certificate purchasing toward more direct support for renewable electricity supply in major operating regions.

Disclosure and Assurance Become Central

The report also highlights governance and disclosure work. Aptar said it completed a double materiality assessment aligned with the EU Corporate Sustainability Reporting Directive.

This is significant because CSRD-style materiality requires companies to assess both how sustainability issues affect enterprise value and how the company affects people and the environment. For global suppliers with European exposure, this type of assessment is becoming increasingly important for compliance readiness, investor communication and customer due diligence.

Aptar also said the report was prepared in accordance with the Global Reporting Initiative Standards. The company obtained reasonable assurance from ERM CVS for Scope 1 and Scope 2 greenhouse gas emissions and energy metrics.

It also obtained limited assurance for selected waste, water, product sustainability, and health and safety metrics. This external assurance matters because corporate sustainability reports are increasingly used by investors, customers, and regulators as decision-making documents rather than general communications materials.

Product Life Cycle Work Remains a Key Focus

The product dimension is another central part of the report. Aptar said it continues to focus on understanding the life cycle impacts of its products and innovating to deliver performance across the value chain and product life cycle.

This is particularly relevant in packaging and drug delivery, where sustainability trade-offs can be complex. A product may need to meet strict safety, hygiene, shelf-life, dosing or regulatory requirements while also reducing material use, improving recyclability, incorporating recycled content, or supporting reuse models.

In consumer packaging, circularity concerns often focus on recyclability, plastic reduction and compatibility with existing waste management systems. In healthcare and pharmaceutical applications, the challenge can be more difficult because product safety, contamination control, regulatory approval and patient usability may limit design options.

Aptar’s role across both consumer and pharmaceutical markets means its sustainability strategy must address different levels of technical and regulatory complexity.

Why this Matters for Customers

Aptar’s broader business context also matters. The company serves thousands of customers across multiple sectors, meaning its sustainability initiatives may have relevance across cosmetics, personal care, food packaging, beverage systems, home care and drug delivery.

For customers, the key practical question is whether supplier-level progress translates into measurable product-level improvements. Renewable electricity can reduce the operational footprint of manufacturing, but companies increasingly need more granular data.

That includes life cycle assessments, recycled-content claims, recyclability evidence, product carbon footprint information and packaging compliance documentation. Aptar’s emphasis on life cycle impacts suggests that these customer demands are becoming more central to its sustainability work.

Implications for Investors and Regulators

For investors, the report provides a view of how Aptar is responding to several converging pressures: decarbonization targets, circular economy expectations, sustainability assurance, CSRD-style disclosure requirements and demand for lower-impact packaging systems.

The company’s use of external assurance and GRI-based reporting may help strengthen confidence in selected metrics, although stakeholders will still need to review the full report to assess year-on-year emissions performance, target boundaries, renewable electricity sourcing details, waste trends, water impacts and product sustainability indicators.

The release also reflects a broader trend in industrial sustainability reporting. Companies are moving from broad ESG narratives toward more structured disclosures that combine operational data, value chain analysis, assurance and regulatory readiness.

For suppliers such as Aptar, this shift is not only about reputational performance. It is increasingly tied to procurement, customer retention, product innovation and access to markets where sustainability data is becoming part of commercial decision-making.

A Supplier-Level Signal for Packaging and Healthcare Value Chains

Aptar’s 2025 report therefore represents more than a standalone sustainability update. It shows how a global packaging and dispensing technology supplier is positioning itself as customers, regulators and investors ask for stronger evidence on emissions, circularity and product impact.

The next test will be whether the company can continue converting renewable power procurement, life cycle analysis and product design work into measurable reductions across its operations and value chain.

Source: www.esgtoday.com